Environmental Financial Reporting and Corporate Performance of Listed Pharmaceutical Companies in Nigeria

A nation's economic growth and development depend critically on the pharmaceutical business because of its inextricable link to people's health and, by extension, their ability to put in productive hours at work. This study analyzed the effect of environmental financial reporting on the profitability of publicly listed pharmaceutical companies in Nigeria. The study relied on the ex post facto research design and made use of historical financial data on the adopted study variables. At the 0.05 threshold of significance as decision criteria, the study tested two hypotheses. The research used secondary data, and the businesses studied were a representative sample of the pharmaceutical companies listed on the Nigerian Exchange Group. Ordinary least square regression was used in conjunction with E-views version 9 to analyze the collected data. Earnings per share of listed pharmaceutical businesses in Nigeria were shown to be favorably connected with environmental financial reporting proxy by employee's welfare policy and community development cost. Management was urged to invest more in their workers' well-being to boost morale and productivity in the pharmaceutical industry.